Athanor Capital, LP Novavax Inc Transaction History

Athanor Capital, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$121.0 - $257.67 $644,325 - $1.37 Million	-5,325 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$112.98 - $319.93 $742,843 - $2.1 Million	-6,575 Reduced 55.25%	5,325 $965,000
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $937,005 - $1.66 Million	11,900 New	11,900 $1.33 Million

286

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $713M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.